Patients were provided with the drugs from the National antituberculous program comprising two regimens: regimen 1: 2 SHRZ / 6 HE for new GUTB patients; regimen 2: 2 SHRZE / 1 HRZE / 5 H3 R3 E3 for recurrent GUTB patients.